Half-year report · HY
3154.TEDINET S100XKN4
Period2025-07-01 → 2025-12-31
Filed2026-02-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥149.2bn | 2025-07-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥288.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥142.7bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Operating income | ¥585m | 2025-07-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥751m | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥817m | 2025-07-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥983m | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥803m | 2025-07-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥983m | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥387m | 2025-07-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥407m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥388m | 2025-07-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥407m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥127.6bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥113.0bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥119.8bn | at 2024-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥107.4bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥92.5bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥20.3bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.5bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.0bn | at 2024-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥19.2bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.3bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥19.2bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.3bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.5bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥1.6bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.0bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥605m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥7.1bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥586m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥17.41 | 2025-07-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.91 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.32 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥17.39 | 2025-07-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥61.85 | 2024-07-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥18.32 | 2024-07-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 15.9% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.1% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 16.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2025-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2025-12-31 | −¥9m |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2025-12-31 | −¥4.2bn |
| Medical Equipment Salesreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥146.1bn |
| Medical Equipment Salesreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥146.1bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥9m |
| Medical Equipment Salesreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥4.5bn |
| Nursing Care And Welfarereportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥3.1bn |
| Nursing Care And Welfarereportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥3.1bn |
| Nursing Care And Welfarereportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥308m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-07-01 → 2025-12-31 | ¥149.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-07-01 → 2025-12-31 | ¥149.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-07-01 → 2025-12-31 | ¥4.8bn |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥9m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥4.5bn |
| Medical Equipment Salesreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥139.7bn |
| Medical Equipment Salesreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥139.7bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥9m |
| Medical Equipment Salesreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥5.0bn |
| Nursing Care And Welfarereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| Nursing Care And Welfarereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥3.0bn |
| Nursing Care And Welfarereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥250m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥142.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥142.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥5.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 563
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision for loss on guarantees | Prior1YearInstant | 106478000 | JPY |
| Provision for loss on guarantees | InterimInstant | 121395000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 1543990000 | JPY |
| Net defined benefit liability | InterimInstant | 1597939000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 162335000 | JPY |
| Asset retirement obligations ncl | InterimInstant | 162537000 | JPY |
| Long term unearned revenue | Prior1YearInstant | 3114030000 | JPY |
| Long term unearned revenue | InterimInstant | 3024925000 | JPY |
| Other ncl | Prior1YearInstant | 1589899000 | JPY |
| Other ncl | InterimInstant | 1522616000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 11167568000 | JPY |
| Noncurrent liabilities | InterimInstant | 10660357000 | JPY |
| Liabilities | Prior1YearInstant | 92546850000 | JPY |
| Liabilities | InterimInstant | 107353196000 | JPY |
| Capital stock | Prior1YearInstant | 1380877000 | JPY |
| Capital stock | InterimInstant | 1380877000 | JPY |
| Capital surplus | Prior1YearInstant | 2879912000 | JPY |
| Capital surplus | InterimInstant | 2879703000 | JPY |
| Retained earnings | Prior1YearInstant | 14206045000 | JPY |
| Retained earnings | InterimInstant | 14148626000 | JPY |
| Treasury stock | Prior1YearInstant | -450000 | JPY |
| Treasury stock | InterimInstant | -450000 | JPY |
| Shareholders equity | Prior1YearInstant | 18466385000 | JPY |
| Shareholders equity | InterimInstant | 18408756000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 1944633000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | 1798534000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 67110000 | JPY |
| Remeasurements of defined benefit plans | InterimInstant | 68605000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 2011744000 | JPY |
| Valuation and translation adjustments | InterimInstant | 1867139000 | JPY |
| Non controlling interests | Prior1YearInstant | － | JPY |
| Non controlling interests | InterimInstant | 9918000 | JPY |
| Net assets | Prior1YearInstant | 20478129000 | JPY |
| Net assets | InterimInstant | 20285814000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 113024980000 | JPY |
| Liabilities and net assets | InterimInstant | 127639011000 | JPY |
| Net sales | Prior1InterimDuration | 142704820000 | JPY |
| Net sales | InterimDuration | 149211026000 | JPY |
| Cost of sales | Prior1InterimDuration | 125826257000 | JPY |
| Cost of sales | InterimDuration | 131881593000 | JPY |
| Gross profit | Prior1InterimDuration | 16878562000 | JPY |
| Gross profit | InterimDuration | 17329432000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1InterimDuration | 9003000 | JPY |
| Provision of allowance for doubtful accounts sga | InterimDuration | 26156000 | JPY |
| Provision for share based payments sga | Prior1InterimDuration | 1510000 | JPY |
| Provision for share based payments sga | InterimDuration | 4439000 | JPY |
| Salaries and allowances sga | Prior1InterimDuration | 6604342000 | JPY |
| Salaries and allowances sga | InterimDuration | 6818799000 | JPY |
| Employees bonuses sga | Prior1InterimDuration | 1459622000 | JPY |
| Employees bonuses sga | InterimDuration | 1511628000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |